Navigation Links
BTAstat Test

ProductsBTAstat Test
Company Mentor Corporation
Item BTAstat Test
Features 
  • Reimbursable
  • CLIA-Waived
  • Supported by over 40 peer publications
Description The BTA stat Test is an in vitro immunoassay intended for the qualititive ("yes or "no) detection of bladder tumor associated antigen. It is indicated for use as an aid in the management of bladder cancer in conjunction with cystoscopy or when prescribed for in home use. BTA stat Test was cleared by the FDA for prescription home use in February 1999. The BTA stat Test detects a substance produced by bladder tumors, if present in a urine sample.
Info Mentor Corporation
Customer Service: (800) 525-0245
Web site: http://www.mentorcorp.com/index-us.htm

Related medicine products :

1. MYDON Long-Pulsed Nd:YAG Laser System
2. Full Handle Laseredge Stab Blade Knife, 15 blade
3. Full Handle Laseredge Stab Blade Knife, 15 blade, 3 mm
4. Full Handle Laseredge Stab Blade Knife, 22.5 blade
5. Full Handle Laseredge Stab Blade Knife, 45 blade
6. Full Handle Laseredge Stab Blade Knife, 30 blade
7. Full Handle Laseredge Crescent Blade Knife, angled bevel up
8. Full Handle Laseredge Crescent Blade Knife, straight
9. Full Handle Laseredge Crescent Blade Knife, angled double bevel
10. Full Handle Laseredge Crescent Blade Knife, angled bevel down
11. Full Handle Laseredge Implant Blade Knife, 4.0 mm straight
Breaking Medicine News(10 mins):Health News:Controversial kidney transplant technique could provide lifeline for very ill patients 2Health News:BridgeGate International Announces New Integration and Interoperability Training Program 2Health News:BridgeGate International Announces New Integration and Interoperability Training Program 3Health News:BridgeGate International Announces New Integration and Interoperability Training Program 4Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 2Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4